Thomas R Staab II has an estimated net worth of $4.14 Million. This is based on reported shares across multiple companies, which include BIOCRYST PHARMACEUTICALS INC, LENSAR, Inc., INSPIRE PHARMACEUTICALS INC, and TENAX THERAPEUTICS, INC..
2018 was Thomas R Staab II's most active year for acquiring shares with 18 total transactions. Thomas R Staab II's most active month to acquire stocks was the month of December. 2018 was Thomas R Staab II's most active year for disposing of shares, totalling 37 transactions. Thomas R Staab II's most active month to dispose stocks was the month of April. 2012 saw Thomas R Staab II paying a total of $146,630.00 for 48,589 shares, this is the most they've acquired in one year. In 2014 Thomas R Staab II cashed out on 173,404 shares for a total of $702,661.73, their largest year based on trade value.